Skip to main content
OpenTrials

Clinical trial condition

Sarcoma

Explore clinical trials studying Sarcoma. Study availability and eligibility vary by location and protocol.

629 public trials 172 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma trial results

Completed

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

NCT00899275

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 180 locations
View Trial Details
Completed

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

NCT02095132

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +37 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

NCT03245151

Conditions
Central Nervous System Neoplasms, Disease Attributes, Glioma, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Miller Children's and Women's Hospital Long Beach, California, United States
View all 50 locations
View Trial Details
Completed

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

NCT00667342

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Malignant Fibrous Histiocytoma (MFH) of Bone, +8 more
Locations
  • Rady Children's Hospital and Health Center San Diego, California, United States
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • NCI/NIH - Pediatric Oncology Branch Bethesda, Maryland, United States
  • St Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Completed

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

NCT02432274

Conditions
Differentiated Thyroid Cancer (DTC), Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Texas Children's Hospital Houston, Texas, United States
  • CHU Strasbourg - Hopital Hautepierre Strasbourg, Bas Rhin, France
  • Centre Oscar Lambret Lille Lille, Rhone, France
  • Centre Leon Berard Lyon, Rhone, France
View all 19 locations
View Trial Details
Completed

M6620 (VX-970) in Selected Solid Tumors

NCT03718091

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Boston Children Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

NCT00134030

Conditions
Localized Osteosarcoma, Metastatic Osteosarcoma, Neoplasms, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 218 locations
View Trial Details
Completed

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

NCT04593758

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +3 more
Locations
  • City of Hope Duarte, California, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Atrium Health Wake Forest Baptist Winston-Salem, North Carolina, United States
View Trial Details

Related conditions